AstraZeneca

ASTRAZEN.NS

Tags: IN Healthcare Drug Manufacturers - Specialty & Generic

AstraZeneca Pharma India Limited Price (ASTRAZEN.NS)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

25,000,000

(0)%

Market Cap of AstraZeneca (ASTRAZEN.NS)

Market cap:

As of , ASTRAZEN.NS has a market cap of . This makes ASTRAZEN.NS the 333th most valuable company in the IN by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Revenue and Profitability

Year	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Revenue	2,224,211,797	2,644,104,423	2,973,136,605	3,397,684,978	3,855,211,715	5,940,250,407	5,312,796,578	3,888,248,920	4,737,481,595	4,690,487,858	5,264,597,783	5,395,700,832	5,710,000,000	7,282,400,000	8,317,700,000	8,085,600,000	8,056,000,000	10,029,708,000	12,955,300,000
Net Income	430,581,328	487,361,780	614,586,110	738,351,827	576,172,441	641,297,533	197,651,248	-895,322,977	-5,089,176	-208,397,042	52,589,820	244,422,513	259,100,000	544,500,000	722,100,000	933,000,000	616,000,000	992,900,000	1,615,100,000
FCF USD	202,952,314	471,164,855	328,640,472	768,208,080	254,524,022	322,263,667	-21,162,591	-248,224,064	-224,413,190	-695,057,588	479,436,000	326,734,540	25,100,000	362,900,000	732,000,000	970,700,000	911,800,000	497,781,000	171,100,000
OCF USD	280,876,285	546,205,097	397,063,414	816,481,552	325,714,122	645,010,351	377,264,434	-60,360,548	-8,076,187	-457,005,200	569,885,205	383,088,876	87,900,000	549,800,000	874,200,000	1,047,800,000	1,008,000,000	582,981,000	278,700,000

Financial Health - DEBT

Year	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
YTPD	0.00	0.00	0.00	0.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08	0.07	0.06	0.03	0.02
D/E	0.01	0.01	0.01	0.55	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.03	0.02	0.01	0.01
CA/CL	2.96	2.10	2.43	2.33	2.24	1.75	1.30	0.80	1.12	1.01	1.08	1.37	1.55	1.56	1.66	2.04	2.12	2.18	2.61
TA/TL	3.64	2.44	2.83	1.67	2.62	2.39	2.24	1.48	1.70	1.58	1.62	1.91	2.16	2.15	2.07	2.43	2.48	2.49	2.94
Total Debt	9,860,000	9,860,000	9,860,000	634,860,000	9,860,000	0	0	2,913,051	2,751,658	2,751,658	0	0	0	0	118,400,000	121,400,000	86,300,000	72,135,600	45,900,000

Management Performance

Year	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
ROIC	33.59%	34.15%	34.55%	38.00%	40.15%	33.06%	8.53%	-102.24%	-16.25%	-22.40%	-0.40%	7.51%	7.96%	13.95%	19.06%	19.66%	11.93%	11.75%	45.54%
ROE	33.85%	34.39%	38.58%	63.57%	39.87%	35.69%	10.44%	-89.75%	-0.30%	-13.82%	3.37%	13.54%	10.49%	18.10%	19.81%	20.45%	12.05%	16.87%	22.69%
ROA	0.00%	31.25%	38.73%	39.68%	37.80%	32.70%	8.55%	-22.96%	-0.12%	-5.06%	1.42%	8.79%	9.51%	12.94%	16.13%	16.40%	9.69%	13.62%	14.98%
NM %	19.36%	18.43%	20.67%	21.73%	14.95%	10.80%	3.72%	-23.03%	-0.11%	-4.44%	1.00%	4.53%	4.54%	7.48%	8.68%	11.54%	7.65%	9.90%	12.47%
FCF / R%	0.00%	17.82%	11.05%	22.61%	6.60%	5.43%	-0.40%	-6.38%	-4.74%	-14.82%	9.11%	6.06%	0.44%	4.98%	8.80%	12.01%	11.32%	4.96%	1.32%
FCF / NI%	31.33%	62.86%	34.47%	67.17%	28.79%	31.92%	-7.23%	35.32%	4,409.62%	333.53%	831.83%	98.40%	5.73%	49.94%	64.23%	76.38%	109.80%	37.12%	10.59%
Operating Margin (OM)	0.00	0.52	0.52	0.33	0.36	0.29	0.35	0.11	0.09	0.04	0.05	0.09	0.20	0.23	0.28	0.40	0.47	0.45	0.45

Per Share

Year	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
EPS	17.22	19.49	24.58	29.53	23.05	25.65	7.91	-35.81	-0.20	-8.34	2.10	9.78	10.36	21.78	28.88	37.32	24.64	39.72	64.60
SPS	88.97	105.76	118.93	135.91	154.21	237.61	212.51	155.53	189.50	187.62	210.58	215.83	228.40	291.30	332.71	323.42	322.24	401.19	518.21
OCPS	11.24	21.85	15.88	32.66	13.03	25.80	15.09	-2.41	-0.32	-18.28	22.80	15.32	3.52	21.99	34.97	41.91	40.32	23.32	11.15
FCPS	8.12	18.85	13.15	30.73	10.18	12.89	-0.85	-9.93	-8.98	-27.80	19.18	13.07	1.00	14.52	29.28	38.83	36.47	19.91	6.84
BVPS	50.88	56.69	63.72	46.46	57.81	71.88	75.71	39.90	68.64	60.30	62.41	72.18	98.77	120.32	145.78	182.47	204.56	235.48	284.77

Per Share - CAGR

Year	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
CAGR-EPS	17.22	19.49	24.58	29.53	23.05	25.65	7.91	-35.81	-0.20	-8.34	2.10	9.78	10.36	21.78	28.88	37.32	24.64	39.72	64.60
CAGR-SPS	88.97	105.76	118.93	135.91	154.21	237.61	212.51	155.53	189.50	187.62	210.58	215.83	228.40	291.30	332.71	323.42	322.24	401.19	518.21
CAGR-OCPS	11.24	21.85	15.88	32.66	13.03	25.80	15.09	-2.41	-0.32	-18.28	22.80	15.32	3.52	21.99	34.97	41.91	40.32	23.32	11.15
CAGR-FCPS	8.12	18.85	13.15	30.73	10.18	12.89	-0.85	-9.93	-8.98	-27.80	19.18	13.07	1.00	14.52	29.28	38.83	36.47	19.91	6.84
CAGR-BVPS	50.88	56.69	63.72	46.46	57.81	71.88	75.71	39.90	68.64	60.30	62.41	72.18	98.77	120.32	145.78	182.47	204.56	235.48	284.77

Revenue $12.96B

+29.17%

10Y

Net Income $1.62B

+62.66%

10Y

Operating Cash Flow $278.70M

-52.19%

10Y

Free Cash Flow $171.10M

-65.63%

10Y

YTPD $0.02

-37.44%

10Y

D/E $0.01

-47.38%

10Y

CA/CL $2.61

+20.02%

10Y

TA/TL $2.94

+18.45%

10Y

ROIC $45.54%

+287.63%

10Y

ROE $22.69%

+34.51%

10Y

ROA $14.98%

+10.03%

10Y

Net Margin $12.47%

+25.93%

10Y

FCF / R% $1.32%

-73.39%

10Y

FCFNI % $10.59%

-71.46%

10Y

Operating Margin $0.45

-1.77%

10Y

EPS $64.60

+62.66%

10Y

SPS $518.21

+29.17%

10Y

OCPS $11.15

-52.19%

10Y

FCPS $6.84

-65.63%

10Y

BVPS $284.77

+20.93%

10Y

Wordpress Tutorials

eCommerce Website Tutorials

Responsive Design

AstraZeneca

Stock Price

Fetching Data...

Fetching Data...

Fetching Data...

25,000,000

Market Cap of AstraZeneca (ASTRAZEN.NS)

Market cap:

Year

Beginning Of Year

End Of Year

YOY Change

Revenue of AstraZeneca (ASTRAZEN.NS)

Revenue:

Year

Revenue

YOY Change

Net Income of AstraZeneca (ASTRAZEN.NS)

Net Income:

Year

Net Income

YOY Change

Free Cash Flow of AstraZeneca (ASTRAZEN.NS)

Free Cash Flow:

Year

FreeCash flow

YOY Change

Operating Cash Flow of AstraZeneca (ASTRAZEN.NS)

Operating Cash Flow:

Year

Operating Cashflow

YOY Change

Return on Invested capital of AstraZeneca (ASTRAZEN.NS)

Return on Invested capital: %

%

Year

Return on Invested Capital

YOY Change

Return on Equity of AstraZeneca (ASTRAZEN.NS)

Return on Equity: %

%

Year

Return on Equity

YOY Change

Return on Assets of AstraZeneca (ASTRAZEN.NS)

Return on Assets: %

%

Year

ROA

YOY Change

Total debt of AstraZeneca (ASTRAZEN.NS)

Total debt:

Year

MarketCap

YOY Change

Marketing Budget of AstraZeneca (ASTRAZEN.NS)

Marketing Budget:

Year

MarketCap

YOY Change

Employee of AstraZeneca (ASTRAZEN.NS)

Employee:

Year

Employees Number

YOY Change

Payroll of AstraZeneca (ASTRAZEN.NS)

Payroll:

Year

Payroll

YOY Change

Dividends of AstraZeneca (ASTRAZEN.NS)

Dividends:

Year

Dividends

YOY Change

Executive Compensation of AstraZeneca (ASTRAZEN.NS)

Executive Compensation: